Merck KGaA in talks with investors to share cost of trials: FT

FRANKFURT (Reuters) - German drugs and healthcare group Merck KGaA is in talks with external investors including private equity firms to share the cost of some clinical trials, the Financial Times said, citing a senior manager at the company. The diversified group is also exploring more "risk-sharing" deals under which the company would receive a fee linked to the success of some of its products including in-vitro fertility treatments, the newspaper said on Monday, citing Stefan Oschmann, executive board member. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/merck-kgaa-talks-investors-share-cost-trials-ft-070151429--sector.html